Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Oximes are a mainstay of treatment in toxicology. All of the following poisonings are indications for using oximes, EXCEPT:

Baygon (Propoxur). ### Explanation The core concept here is the difference between **Organophosphates (OP)** and **Carbamates** in their interaction with the enzyme Acetylcholinesterase (AChE). **1. Why Baygon (Propoxur) is the Correct Answer:** Baygon is a **Carbamate**. Unlike Organophosphates, carbamates cause **reversible** inhibition of AChE. The carbamoyl-enzyme complex dissociates spontaneously and rapidly (usually within minutes to hours). Furthermore, carbamates do not undergo "aging" (the permanent covalent bonding seen in OP poisoning). * **Contraindication:** Oximes (like Pralidoxime) are generally **avoided** in carbamate poisoning because they are unnecessary and may actually inhibit AChE further, potentially worsening the toxicity (especially in Carbaryl poisoning). **2. Why the other options are incorrect:** * **Malathion and Parathion (Options C & D):** These are classic Organophosphates. They cause irreversible inhibition of AChE by phosphorylating the enzyme. Oximes are essential here to "rescue" the enzyme before "aging" occurs. * **Tik-20 (Option A):** This is a common brand name for an Organophosphate insecticide (often containing Malathion or Fenitrothion). As an OP compound, it is a primary indication for oxime therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Oximes:** They act as "Cholinesterase Reactivators" by displacing the phosphate group from the enzyme, but only **before aging** occurs. * **Aging:** Once the enzyme-phosphate bond matures (aging), oximes are ineffective. This is why they must be given early (ideally within 24–48 hours). * **Atropine vs. Oximes:** Atropine is the physiological antidote (blocks muscarinic receptors) for **both** OP and Carbamates. Oximes are the specific biochemical antidote for **OP only**. * **Mnemonic:** "Oximes for Organophosphates" (Both start with 'O'). Avoid Oximes for Carbamates (except in rare mixed poisonings).

Q: Which antibiotic can accentuate the neuromuscular blockade produced by d-tubocurarine?

Streptomycin. **Explanation:** The correct answer is **Streptomycin**. **Mechanism of Interaction:** Aminoglycoside antibiotics (like Streptomycin, Gentamicin, and Neomycin) possess a known side effect of neuromuscular blockade. They interfere with neuromuscular transmission by two primary mechanisms: 1. **Inhibition of Acetylcholine (ACh) release:** They compete with Calcium ions at the pre-junctional nerve terminal, reducing the amount of ACh released. 2. **Post-junctional sensitivity:** They decrease the sensitivity of the motor end-plate to ACh. When administered with non-depolarizing neuromuscular blockers like **d-tubocurarine**, these effects are additive, leading to prolonged respiratory paralysis or "apnea." **Analysis of Incorrect Options:** * **A. Penicillin G:** A cell-wall synthesis inhibitor (Beta-lactam) that does not interfere with calcium channels or ACh release; it has no effect on the neuromuscular junction. * **B. Erythromycin:** A Macrolide that inhibits protein synthesis (50S subunit). While it can interact with drugs via CYP3A4 inhibition, it does not potentiate neuromuscular blockade. * **D. Chloramphenicol:** Another protein synthesis inhibitor (50S subunit) primarily associated with bone marrow suppression and Gray Baby Syndrome, but not neuromuscular interference. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Potency:** Among aminoglycosides, the neuromuscular blocking potency is: **Neomycin > Streptomycin > Amikacin > Gentamicin.** * **Management:** Aminoglycoside-induced blockade can be partially reversed by **Intravenous Calcium Gluconate** (which overcomes the pre-junctional calcium competition) and Neostigmine. * **Contraindication:** Aminoglycosides should be used with extreme caution in patients with **Myasthenia Gravis** as they can precipitate a myasthenic crisis.

Q: A patient on indinavir treatment presents with jaundice. Detailed evaluation reveals that the elevated bilirubin is mainly the indirect fraction. What is the probable mechanism of indirect hyperbilirubinemia in this setting?

Decreased conjugation. ### Explanation **Correct Option: C. Decreased conjugation** Indinavir, a Protease Inhibitor (PI) used in HIV treatment, is well-known to cause asymptomatic **indirect (unconjugated) hyperbilirubinemia**. The underlying mechanism is the **potent inhibition of Uridine diphosphate-glucuronosyltransferase (UGT1A1)**, the enzyme responsible for conjugating bilirubin in the liver. This mimics the clinical presentation of **Gilbert Syndrome**. Since the bilirubin cannot be conjugated, it remains in the indirect form, leading to jaundice without significant elevation of transaminases or alkaline phosphatase. **Analysis of Incorrect Options:** * **A. Increased bilirubin production:** This typically occurs in states of massive cell turnover or ineffective erythropoiesis, which is not the mechanism for indinavir-induced jaundice. * **B. Decreased hepatocellular uptake:** While some drugs (like Rifampicin) can interfere with the uptake of bilirubin into hepatocytes via OATP transporters, Indinavir specifically targets the enzymatic conjugation step. * **D. Hemolysis:** Although hemolysis causes indirect hyperbilirubinemia, Indinavir does not typically cause red cell breakdown. In hemolysis, you would also expect low haptoglobin and elevated LDH, which are absent here. **High-Yield Clinical Pearls for NEET-PG:** * **Indinavir Side Effects:** Remember the triad: **Indirect Hyperbilirubinemia**, **Nephrolithiasis** (crystalluria—patients must stay hydrated), and **Lipodystrophy** (buffalo hump/insulin resistance). * **Atazanavir:** Another Protease Inhibitor that frequently causes indirect hyperbilirubinemia via the same UGT1A1 inhibition mechanism. * **Gilbert Syndrome Link:** Patients with pre-existing Gilbert Syndrome are at a much higher risk of developing visible jaundice when started on Indinavir or Atazanavir.

Q: What is the primary purpose of pharmacovigilance?

To monitor drug toxicity. **Explanation:** **Pharmacovigilance (PV)** is defined by the WHO as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems [1]. **Why Option A is correct:** The primary goal of pharmacovigilance is to ensure patient safety by monitoring the **toxicity** and safety profile of drugs after they have been released into the market (Phase IV: Post-marketing surveillance) [1], [2]. Since clinical trials involve a limited number of participants, rare or long-term adverse drug reactions (ADRs) often only surface when the drug is used by the general population [1]. PV systems identify these "signals" to update drug labels or, if necessary, withdraw dangerous drugs from the market [2]. **Why other options are incorrect:** * **Option B:** Monitoring unauthorized manufacture is a regulatory and legal function (Drug Controller General of India/FDA), not a clinical pharmacology function. * **Option C:** Monitoring students is an academic/administrative task unrelated to drug safety. * **Option D:** Drug cost monitoring (Pharmacoeconomics) deals with the cost-benefit analysis of therapy, not the clinical safety of the molecule. **High-Yield Clinical Pearls for NEET-PG:** * **Phase IV Clinical Trial:** This is the phase synonymous with pharmacovigilance. * **Pharmacovigilance Programme of India (PvPI):** Launched in 2010; the National Coordinating Centre is the **Indian Pharmacopoeia Commission (IPC)**, Ghaziabad. * **Uppsala Monitoring Centre (UMC):** Located in Sweden, it is the WHO's international hub for ADR monitoring. * **Yellow Card Scheme:** A famous ADR reporting system used in the UK (often asked in international context).

Q: Which drug should be avoided in a patient with a known allergy to penicillin?

Ampicillin. **Explanation:** The correct answer is **Ampicillin** because it belongs to the **Penicillin group** of antibiotics. **1. Why Ampicillin is the Correct Choice:** Ampicillin is a semi-synthetic, broad-spectrum penicillin. All drugs within the penicillin class share a common **6-aminopenicillanic acid** nucleus and a **Beta-lactam ring**. If a patient is allergic to penicillin, they are hypersensitive to this core structure. Administering Ampicillin would trigger a cross-reactivity reaction, ranging from a mild skin rash to life-threatening **Type I hypersensitivity (Anaphylaxis)**. **2. Why Other Options are Incorrect:** * **Sulphonamides (A):** These are synthetic bacteriostatic agents (e.g., Sulfamethoxazole). While they are common allergens, they do not share structural similarity with the Beta-lactam ring. * **Tetracycline (B):** This is a protein synthesis inhibitor (30S subunit). It is chemically distinct from penicillins and is safe to use in penicillin-allergic patients. * **Chloramphenicol (D):** This is a broad-spectrum antibiotic that inhibits the 50S ribosomal subunit. It does not cross-react with penicillins. **3. Clinical Pearls for NEET-PG:** * **Cross-Reactivity with Cephalosporins:** Patients with a penicillin allergy have a **3–10% risk** of cross-reactivity with first-generation cephalosporins (e.g., Cephalexin). The risk is much lower with third-generation agents (e.g., Ceftriaxone). * **Safe Alternatives:** For Gram-positive infections in penicillin-allergic patients, **Macrolides** (Erythromycin/Azithromycin) or **Clindamycin** are often the drugs of choice. * **Monobactams:** **Aztreonam** is the only Beta-lactam that generally does *not* cross-react with penicillins (except for a specific cross-sensitivity with Ceftazidime).

Q: Which of the following drugs, when administered in high doses, can cause convulsions?

Penicillin. **Explanation:** **1. Why Penicillin is the Correct Answer:** High doses of Penicillins, particularly **Penicillin G**, are well-known to be neurotoxic. The underlying mechanism is the **antagonism of GABA-A receptors** in the central nervous system. Since GABA is the primary inhibitory neurotransmitter, its blockade leads to neuronal hyperexcitability, which can manifest as myoclonus or generalized tonic-clonic **convulsions**. This risk is significantly increased in patients with **renal failure** (due to drug accumulation) or those with pre-existing seizure disorders. **2. Why Other Options are Incorrect:** * **Aminoglycosides (e.g., Gentamicin):** These are primarily associated with **ototoxicity** (vestibular and cochlear damage) and **nephrotoxicity** (acute tubular necrosis). They do not typically cause CNS excitation or seizures. * **Erythromycin (Macrolide):** The hallmark adverse effects of Macrolides include GI upset, **cholestatic jaundice** (especially with Erythromycin estolate), and **QT interval prolongation**. They are not associated with convulsions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Other Antibiotics causing Seizures:** Apart from Penicillins, **Imipenem** (a Carbapenem) and **Fluoroquinolones** (e.g., Ciprofloxacin) are high-yield causes of drug-induced seizures. * **Imipenem vs. Meropenem:** Imipenem has a higher seizure potential than Meropenem; hence Meropenem is preferred in CNS infections like meningitis. * **Ceftriaxone:** While most Beta-lactams can cause seizures at very high doses, Ceftriaxone is more commonly noted for causing **biliary sludge** (pseudolithiasis). * **Management:** Drug-induced seizures are generally managed by discontinuing the offending agent and administering **Benzodiazepines**.

Q: All of the following statements are true regarding warfarin toxicity (skin necrosis) except?

Most common sites are toes and tips of fingers.. **Explanation:** **Warfarin-Induced Skin Necrosis (WISN)** is a rare but serious complication occurring due to a transient hypercoagulable state during the initiation of therapy. **Why Option B is the Correct Answer (The False Statement):** The most common sites for skin necrosis are areas with **abundant subcutaneous fat**, such as the **breasts, thighs, buttocks, and abdomen**. It is caused by microvascular thrombosis in the dermal capillaries. In contrast, "Purple Toe Syndrome" (a different warfarin complication) involves the toes, but true skin necrosis preferentially affects fatty tissues. **Analysis of Other Options:** * **Option A:** True. It typically occurs within **3–10 days** of starting therapy. * **Option C:** True. Warfarin inhibits Vitamin K-dependent factors (II, VII, IX, X) and anticoagulant proteins (Protein C and S). **Protein C has a shorter half-life** (~6 hours) than procoagulant factors like Factor II and X. Thus, Protein C levels drop rapidly, creating a temporary prothrombotic window. Patients with hereditary Protein C deficiency are at the highest risk. * **Option D:** True. Starting **LMWH or Unfractionated Heparin** as "bridge therapy" provides immediate anticoagulation, counteracting the transient hypercoagulability until the procoagulant factors are sufficiently depleted. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Rapid depletion of Protein C → Relative hypercoagulability → Microvascular thrombosis → Skin necrosis. * **Management:** Discontinue Warfarin, administer **Vitamin K**, and provide **Protein C concentrates** or Fresh Frozen Plasma (FFP). Continue Heparin for anticoagulation. * **Key Risk Factor:** Loading doses of Warfarin (e.g., >10mg) increase the risk of WISN.

Q: In which clinical trial phase are healthy human volunteers typically used?

Phase I. The correct answer is **Phase I**. Clinical trials are conducted in a sequential manner to ensure drug safety and efficacy before and after market approval. **Why Phase I is correct:** Phase I is the first stage of testing a new drug in humans (First-in-human trials). It typically involves a small group (20–80) of **healthy human volunteers** [1]. The primary objective is to determine **safety, tolerability, and pharmacokinetics** (ADME) [1]. An exception occurs with highly toxic drugs, such as anti-cancer agents, where Phase I trials are conducted directly on patients. **Analysis of Incorrect Options:** * **Phase II (Therapeutic Exploratory):** This phase is conducted on a small group of **patients** (100–300) with the target disease [2]. Its primary goal is to assess **efficacy** and determine the optimal dose-range [2]. * **Phase III (Therapeutic Confirmatory):** This involves a large-scale multicentric study on thousands of **patients**. It aims to confirm efficacy, monitor side effects, and compare the drug with existing treatments (standard of care) or placebos. * **Phase IV (Post-Marketing Surveillance):** This occurs after the drug is approved and marketed. It monitors long-term safety and detects **rare adverse effects** in the general population. **High-Yield Clinical Pearls for NEET-PG:** * **Phase 0 (Microdosing):** Uses sub-therapeutic doses in humans to study pharmacokinetics; it does not replace Phase I. * **Maximum Tolerated Dose (MTD):** Identified during Phase I. * **Ceiling Effect:** Often identified during Phase II. * **Phase III** is the most expensive and time-consuming phase. * **Black Box Warnings** are usually a result of Phase IV data.

Q: Which of the following drugs is associated with teratogenic effects?

Lithium. **Explanation:** The correct answer is **Lithium**. While all four drugs listed are technically teratogenic, the context of NEET-PG questions often requires identifying the most characteristic or "classic" association for a specific clinical scenario. Lithium is famously associated with **Ebstein’s Anomaly**, a congenital heart defect characterized by the downward displacement of the tricuspid valve leaflets into the right ventricle ("atrialization" of the ventricle). **Analysis of Options:** * **Lithium (Correct):** Used for Bipolar Disorder. Exposure during the first trimester increases the risk of Ebstein’s Anomaly. * **Valproate:** While highly teratogenic, it is most specifically associated with **Neural Tube Defects** (e.g., Spina Bifida) due to interference with folate metabolism. * **Phenytoin:** Associated with **Fetal Hydantoin Syndrome**, characterized by craniofacial dysmorphism, hypoplastic nails/phalanges, and growth retardation. * **Amiodarone:** Can cause fetal **goiter or hypothyroidism** due to its high iodine content, but it is not the "classic" answer for general teratogenicity questions unless thyroid issues are mentioned. **High-Yield Clinical Pearls for NEET-PG:** 1. **Valproate** has the highest risk of major malformations among all antiepileptics. 2. **Warfarin** causes Fetal Warfarin Syndrome (stippled epiphyses and nasal hypoplasia); **Heparin** is the preferred anticoagulant in pregnancy. 3. **Isotretinoin** is the most potent human teratogen (causes CNS, cardiac, and craniofacial defects); strict contraception is mandatory. 4. **Thalidomide** causes Phocomelia (seal-like limbs). 5. **ACE Inhibitors** cause renal dysgenesis and oligohydramnios in the 2nd/3rd trimesters.

Question 1

Oximes are a mainstay of treatment in toxicology. All of the following poisonings are indications for using oximes, EXCEPT:

Accepted Answer

Baygon (Propoxur)

Answer

Organophosphate insecticide (Tik20)

Answer

Malathion

Answer

Parathion

Question 2

Which antibiotic can accentuate the neuromuscular blockade produced by d-tubocurarine?

Accepted Answer

Streptomycin

Answer

Penicillin G

Answer

Erythromycin

Answer

Chloramphenicol

Question 3

A patient on indinavir treatment presents with jaundice. Detailed evaluation reveals that the elevated bilirubin is mainly the indirect fraction. What is the probable mechanism of indirect hyperbilirubinemia in this setting?

Accepted Answer

Decreased conjugation

Answer

Increased bilirubin production

Answer

Decreased hepatocellular uptake

Answer

Hemolysis

Question 4

What is the primary purpose of pharmacovigilance?

Accepted Answer

To monitor drug toxicity

Answer

To monitor unauthorized drug manufacture

Answer

Monitoring of students

Answer

To check drug costs

Question 5

Which drug should be avoided in a patient with a known allergy to penicillin?

Accepted Answer

Ampicillin

Answer

Sulphonamide

Answer

Tetracycline

Answer

Chloramphenicol

Question 6

Which of the following drugs, when administered in high doses, can cause convulsions?

Accepted Answer

Penicillin

Answer

Aminoglycosides

Answer

Erythromycin

Answer

All of the above

Question 7

All of the following statements are true regarding warfarin toxicity (skin necrosis) except?

Accepted Answer

Most common sites are toes and tips of fingers.

Answer

Skin necrosis occurs during the initiation of therapy.

Answer

Decreased quantity of protein C.

Answer

Decreased incidence of adverse effects if therapy with LMWH is started.

Question 8

In which clinical trial phase are healthy human volunteers typically used?

Accepted Answer

Phase I

Answer

Phase II

Answer

Phase III

Answer

Phase IV

Question 9

Which of the following factors markedly increases the risk of valproate-induced liver toxicity?

Accepted Answer

Age younger than 2 years

Answer

Allergic reactions to phenobarbital

Answer

Male gender

Answer

Family history of epilepsy

Question 10

Which of the following drugs is associated with teratogenic effects?

Accepted Answer

Lithium

Answer

Amiodarone

Answer

Valproate

Answer

Phenytoin

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?